Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy.
Front Immunol. 2020 Mar 6;11:221. doi: 10.3389/fimmu.2020.00221. eCollection 2020.
Front Immunol. 2020.
PMID: 32210954
Free PMC article.
Review.